Chugai Pharmaceutical Co.... (CHGCF)

PNK: CHGCF · Real-Time Price · USD

56.39

0.54 (0.97%)

At close: May 01, 2025, 3:20 PM

Chugai Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	540.2B	458.67B	222.17B	267.75B	212.33B	203.94B	146.86B	139.07B	95.37B
Short-Term Investments	456.14B	280.31B	280.94B	204.22B	166.29B	129.12B	102.53B	104.02B	110.18B
Long-Term Investments	n/a	61.09B	-279.1B	-201.82B	-163.45B	-126.16B	-92.81B	-92.67B	-100.47B
Other Long-Term Assets	73.07B	64.47B	335.29B	246.49B	194.73B	153.87B	131.61B	118.85B	124.14B
Receivables	334.26B	318.89B	512.54B	355.08B	253.34B	181.64B	179.56B	175B	167.48B
Inventory	240.07B	273.48B	292.21B	208.84B	183.89B	168.12B	159.36B	169.06B	185.44B
Other Current Assets	35.38B	13.24B	9.92B	10.47B	4.05B	5.05B	2.21B	2.83B	11.63B
Total Current Assets	1,606B	1,366.4B	1,336.5B	1,063.7B	834.91B	699.68B	600.09B	599.14B	578.76B
Property-Plant & Equipment	441.55B	420.7B	386.65B	352.11B	297.49B	265.31B	222.39B	171.57B	157.08B
Goodwill & Intangibles	17.87B	19.86B	25.14B	21.97B	23.88B	23.54B	22.7B	21.08B	19.3B
Total Long-Term Assets	602.33B	566.12B	533.22B	475.03B	400.59B	359.24B	319.45B	253.33B	227.53B
Total Assets	2,208.4B	1,932.5B	1,869.8B	1,538.7B	1,235.5B	1,058.9B	919.55B	852.47B	806.28B
Account Payables	65.35B	112.47B	209.84B	152.27B	100.4B	77.64B	71.71B	63.52B	72.35B
Deferred Revenue	n/a	n/a	79M	86M	80M	252M	19.57B	18.62B	10.61B
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	129M	135M
Other Current Liabilities	116.27B	131.12B	176.06B	140.65B	104.02B	72.69B	16.49B	15.73B	18.05B
Total Current Liabilities	290.36B	288.22B	423.73B	327.42B	236.07B	179.27B	135.22B	122.9B	123.66B
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	207M	510M
Other Long-Term Liabilities	11.44B	18.37B	21.64B	23.25B	19.43B	25.66B	11.06B	25.13B	24.69B
Total Long-Term Liabilities	16.52B	18.75B	21.64B	23.25B	19.43B	25.66B	27.8B	36.67B	36.13B
Total Liabilities	306.87B	306.97B	445.37B	350.68B	255.5B	204.93B	163.02B	159.58B	159.79B
Total Debt	n/a	13.46B	14.11B	16.04B	11.28B	12.75B	215M	336M	645M
Common Stock	n/a	n/a	73.2B	73.2B	73.2B	73.02B	73B	72.97B	72.97B
Retained Earnings	n/a	1,488.7B	1,293.4B	1,054B	849.09B	722.08B	618.09B	550.97B	507.4B
Comprehensive Income	n/a	-5.71B	-10.97B	-7.46B	-9.88B	-8.14B	-1.27B	3.17B	1.64B
Shareholders Equity	1,901.5B	1,625.6B	1,424.4B	1,188B	980B	853.99B	755.86B	691.92B	645.51B
Total Investments	456.14B	280.31B	1.84B	2.39B	2.84B	2.96B	9.72B	11.35B	9.71B